Results 71 to 80 of about 2,447 (177)
Cardiovascular-kidney-metabolic (CKM) syndrome is defined as the complex interaction of metabolic diseases such as metabolic syndrome (MS), chronic kidney disease (CKD), and cardiovascular disease (CVD).
Yixiao Zhao +2 more
doaj +1 more source
Association between body roundness index and advanced cardiovascular-kidney-metabolic syndrome
BackgroundCardiovascular–kidney–metabolic (CKM) syndrome is a disease characterized by interrelated cardiovascular, renal, and metabolic abnormalities.
Yuehui Chen +3 more
doaj +1 more source
As antiretroviral therapy (ART) prolongs lifespans, people with HIV (PWH) face a new syndemic: Cardiovascular‐Kidney‐Metabolic (CKM) syndrome. Yet CKM in PWH is poorly characterized. Inflammation, complex pharmacokinetic (PK) alterations, ART‐associated metabolic effects, and gut dysbiosis amplify risk. Managing CKM increases medication burden, thereby
Aaron S. Devanathan, Thomas D. Nolin
wiley +1 more source
ABSTRACT Understanding factors associated with early hip osteoarthritis (OA) in young active adults may facilitate hip OA prevention. We investigated the cross‐sectional association between hip contact force (HCF) during walking and cartilage defect severity, accounting for cam morphology size (alpha angle), hip pain severity, sex, age, and walking ...
Kay M. Crossley +15 more
wiley +1 more source
ObjectiveCardiovascular-kidney-metabolic (CKM) syndrome is a major public health issue worldwide. However, direct evidence on dietary modulators in CKM syndrome is lacking.
Qiuming He +9 more
doaj +1 more source
Ultrasonographic evaluation of ulnar innervated muscles in ulnar neuropathy at the elbow
Abstract Background Quantitative muscle ultrasound (qMUS) provides morphological measurements that can support clinical observation of muscle atrophy and weakness. As the use of qMUS continues to expand, and its potential for broader implementation in neuromuscular evaluation grows, there is a clear need for further validation, particularly in ...
Emmanuel Ogalo +7 more
wiley +1 more source
Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review
Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos +16 more
wiley +1 more source
Background The present study aims to investigate the association of smoking behaviors and cardiovascular-kidney-metabolic (CKM) syndrome with incident cardiovascular disease (CVD), and to evaluate whether the cardiovascular benefits of smoking cessation ...
Xinhui Liu +3 more
doaj +1 more source
Background: Cardiovascular-kidney-metabolic (CKM) syndrome is identified as a medical condition with the presence of obesity, diabetes, chronic kidney disease, and cardiovascular disease.
Shunchang Fan +7 more
doaj +1 more source
Diabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 4432-4436, June 2026.
Milton Packer
wiley +1 more source

